Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer

Carcinogenesis

Volumn 24, Issue 4, 2003, Pages 665-671

  Maihöfner, Christian ^a   Charalambous, Michalis Panayiotou ^b   Bhambra, Upinder ^b   Lightfoot, Tracy ^c   Geisslinger, Gerd ^d   Gooderham, Nigel J ^b   Barrett, J ^e   Bishop, D T ^e   Boobis, A R ^e   Forman, D ^e   Garner, R C ^e   Sachse, C ^e   Smith, G ^e   Waxman, R ^e   Wolf, C R ^e  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APOPTOSIS INHIBITOR; AZATHIOPRINE; BENDROFLUMETHIAZIDE; CELL EXTRACT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FERROUS SULFATE; FLUOROURACIL; I KAPPA B; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOPROTEIN; ISOSORBIDE; LEVOBUNOLOL; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PREDNISOLONE; PROPRANOLOL; PROSTAGLANDIN SYNTHASE; PROTEIN HYDROLYSATE; PROTEIN SUBUNIT; SIMVASTATIN; SYNAPTOTAGMIN; UNINDEXED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; STATISTICAL SIGNIFICANCE; STROMA CELL; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-6; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0038393312     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg006     Document Type: Review

References (49)

1. Great Britain Office for National Statistics (1998) Cancer Statistics Registration: England and Wales 1992. HMSO, London.
2. Midgley,R. and Kerr,D. (1999) Colorectal cancer. Lancet, 353, 391-399.
3. Shike,M. (1999) Diet and lifestyle in the prevention of colorectal cancer: an overview. Am. J. Med., 106, 11S-15S.
4. Hill,M.J. (1997) Dietary fibre and human cancer. Epidemiological data. Adv. Exp. Med. Biol., 427, 27-34.
5. Emery,J., Lucassen,A. and Murphy,M. (2001) Common hereditary cancers and implications for primary care. Lancet, 358, 56-63.
6. Redston,M. (2001) Carcinogenesis in the GI tract: from morphology to genetics and back again. Mod. Pathol., 14, 236-245.
7. Williams,C.S., Smalley,W. and DuBois,R.N. (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest., 100, 1325-1329.
8. Smalley,W., Ray,W.A., Daugherty,J. and Griffin,M.R. (1999) Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch. Intern. Med., 159, 161-166.
9. Labayle,D., Fischer,D., Vielh,P., Drouhin,F., Pariente,A., Bories,C., Duhamel,O., Trousset,M. and Attali,P. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101, 635-639.
10. van Stolk,R., Stoner,G., Hayton,W.L., et al. (2000) Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin. Cancer Res., 6, 78-89.
11. Vane,J.R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol., 231, 232-235.
12. Vane,J.R., Bakhle,Y.S. and Botting,R.M. (1998) Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120.
13. Maihofner,C., Tegeder,I., Euchenhofer,C., deWitt,D., Brune,K., Bang,R., Neuhuber,W. and Geisslinger,G. (2000) Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience, 101, 1093-1108.
14. Euchenhofer,C., Maihofner,C., Brune,K., Tegeder,I. and Geisslinger,G. (1998) Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci. Lett., 248, 25-28.
15. Harris,R.C., McKanna,J.A., Akai,Y., Jacobson,H.R., DuBois,R.N. and Breyer,M.D. (1994) Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest., 94, 2504-2510.
16. Maihofner,C., Schlotzer-Schrehardt,U., Guhring,H., et al. (2001) Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest. Ophthalmol. Vis. Sci., 42, 2616-2624.
17. Kargman,S.L., O'Neill,G.P., Vickers,P.J., Evans,J.F., Mancini,J.A. and Jothy,S. (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559.
18. Eberhart,C.E., Coffey,R.J., Radhika,A., Giardiello,F.M., Ferrenbach,S. and DuBois,R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
19. Dimberg,J., Samuelsson,A., Hugander,A. and Soderkvist,P. (1999) Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut, 45, 730-732.
20. Steinbach,G., Lynch,P.M., Phillips,R.K., et al. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342, 1946-1952.
21. Sheng,H., Shao,J., Kirkland,S.C., Isakson,P., Coffey,R.J., Morrow,J., Beauchamp,R.D. and DuBois,R.N. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99, 2254-2259.
22. Piancatelli,D., Romano,P., Sebastiani,P., Adorno,D. and Casciani,C.U. (1999) Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J. Immunother., 22, 25-32.
23. Kinoshita,T., Ito,H. and Miki,C. (1999) Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer, 85, 2526-2531.
24. Yukawa,M., Fujimori,T., Maeda,S., Tabuchi,M. and Nagasako,K. (1994) Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut, 35, 1258-1261.
25. Maihofner,C., Euchenhofer,C., Tegeder,I., Beck,K.F., Pfeilschifter,J. and Geisslinger,G. (2000) Regulation and immunohistochemical localization of nitric oxide synthases and soluble guanylyl cyclase in mouse spinal cord following nociceptive stimulation. Neurosci. Lett., 290, 71-75.
26. Tegeder,I., Niederberger,E., Israr,E., Guhring,H., Brune,K., Euchenhofer,C., Grosch,S. and Geisslinger,G. (2001) Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J., 15, 2-4.
27. Vogiagis,D., Brown,W., Glare,E.M. and O'Brien,P.E. (2001) Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels. Carcinogenesis, 22, 869-874.
28. Grosch,S., Tegeder,I., Niederberger,E., Brautigam,L. and Geisslinger,G. (2001) COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J., 15, 2742-2744.
29. Zhang,Z. and DuBois,R.N. (2001) Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene, 20, 4450-4456.
30. Elder,D.J., Halton,D.E., Crew,T.E. and Paraskeva,C. (2000) Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int. J. Cancer, 86, 553-560.
31. Tardieu,D., Jaeg,J.P., Deloly,A., Corpet,D.E., Cadet,J. and Petit,C.R. (2000) The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis, 21, 973-976.
32. Richter,M., Weiss,M., Weinberger,I., Furstenberger,G. and Marian,B. (2001) Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis, 22, 17-25.
33. Oshima,M., Dinchuk,J.E., Kargman,S.L., Oshima,H., Hancock,B., Kwong,E., Trzaskos,J.M., Evans,J.F. and Taketo,M.M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
34. Masunaga,R., Kohno,H., Dhar,D.K., et al. (2000) Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin. Cancer Res., 6, 4064-4068.
35. Appleby,S.B., Ristimaki,A., Neilson,K., Narko,K. and Hla,T. (1994) Structure of the human cyclo-oxygenase-2 gene. Biochem. J., 302, 723-727.
36. Mayo,M.W. and Baldwin,A.S. (2000) The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta, 1470, M55-M62.
37. Neurath,M.F., Becker,C., and Barbulescu,K. (1998) Role of NF-kappaB in immune and inflammatory responses in the gut. Gut, 43, 856-860.
38. Mayo,M.W., Madrid,L.V., Westerheide,S.D., Jones,D.R., Yuan,X.J., Baldwin,A.S., Jr. and Whang,Y.E. (2002) PTEN blocks TNF-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J. Biol. Chem., 277, 11116-111125.
39. Yang,J.P., Hori,M., Takahashi,N., Kawabe,T., Kato,H. and Okamoto,T. (1999) NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene, 18, 5177-5186.
40. Etoh,T., Shibuta,K., Barnard,G.F., Kitano,S., and Mori,M. (2000) Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin. Cancer Res., 6, 3545-3551.
41. Shimizu,S., Nishikawa,Y., Kuroda,K., Takagi,S., Kozaki,K., Hyuga,S., Saga,S. and Matsuyama,M. (1996) Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res., 56, 3366-3370.
42. Estrov,Z., Kurzrock,R., Estey,E., Wetzler,M., Ferrajoli,A., Harris,D., Blake,M., Gutterman,J.U. and Talpaz,M. (1992) Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood, 79, 1938-1945.
43. Lahm,H., Petral-Malec,D., Yilmaz-Ceyhan,A., Fischer,JR., Lorenzoni,M., Givel,J.C. and Odartchenko,N. (1992) Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1. Eur. J. Cancer, 28A, 1894-1899.
44. Tilg,H., Mier,J.W., Vogel,W., Aulitzky,W.E., Wiedermann,C.J., Vannier,E., Huber,C. and Dinarello,C.A. (1993) Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol., 150, 4687-4692.
45. Estrov,Z., Kurzrock,R. and Talpaz,M. (1995) Interleukin-1 and its inhibitors: implications for disease biology and therapy. Cancer Treat. Res., 80, 51-82.
46. Miyazawa,K., Mori,A., Yamamoto,K. and Okudaira,H. (1998) Transcriptional roles of CCAAT/enhancer binding protein-beta, nuclear factor-kappaB, and C-promoter binding factor 1 in interleukin (IL)-1beta-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J. Biol. Chem., 273, 7620-7627.
47. Song,S.H., Jong,H.S., Choi,H.H., Inoue,H., Tanabe,T., Kim,N.K. and Bang,Y.J. (2001) Transcriptional silencing of cyclooxygenase-2 by hypermethylation of the 5′ CpG island in human gastric carcinoma cells. Cancer Res., 61, 4628-4635.
48. Legrand-Poels,S., Schoonbroodt,S. and Piette,J. (2000) Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line. Biochem. J., 349, 765-773.
49. Vanden Berghe,W., Vermeulen,L., De Wilde,G., De Bosscher,K., Boone,E. and Haegeman,G. (2000) Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol., 60, 1185-1195.